- Those considering cancer treatment
- Early cancer detection
- General medicine practice
- To oncogene diagnosis/medical research facilities personnel
The first UDX Hirahata Clinic Ethics Committee was convened on August 23, 2013 in the fourth-floor conference room of the UDX Building.
When doctors performed genetic diagnosis, gene therapy, and related treatments, an ethical and safety administration review and evaluation were conducted.
|Haruhiko Sugimura||Professor of Tumor Pathology at the Hamamatsu University School of Medicine|
|Ryuichi Yoneyama||Attorney with the Otaka Law Office|
|Mai Tamura||Physician with the Toho University Omori Medical Center’s Department of Dermatology
and the Matsukura Clinic
|Masashi Ito||President and CEO of Fuji Keiki Co. Ltd.|
|Tetsuyuki Hirahata||Chairperson, Medical Corporation Soyukai|
|Koichi Hirahata||Hirahata Clinic Chief, Medical Corporation Soyukai|
＊Records of proceedings are private in order to safeguard technical content.